Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2007-04-27 | Mr. Moran is a graduate of the University of Notre Dame, and holds a master’s degree in business administration from Harvard Business School. |
| 2008-04-25 | Mr. Moran is a graduate of the University of Notre Dame and holds a master's degree in business administration from Harvard Business School. |
| 2009-04-28 | Mr. Moran is a graduate of the University of Notre Dame and holds an M.B.A. from Harvard Business School. |
| 2010-04-22 | Mr. Moran received a Bachelor’s Degree from the University of Notre Dame, and holds a Master’s degree in business administration from the Harvard Business School. |
| 2011-04-28 | Mr. Moran received a Bachelor’s Degree from the University of Notre Dame, and holds a Master’s degree in business administration from the Harvard Business School. |
| 2012-04-25 | Mr. Moran joined the Board of Directors of Anika Therapeutics in December 2006. In 2009, Mr. Moran became the President, CEO and Chairman of Core Essence Orthopaedics. From 1997 to 2009, he was a private investor in a number of companies, mostly in the medical devices field. From 1990 to 1997, Mr. Moran served as the first President of Synthes Spine, a division of Synthes (USA), the leading skeletal fixation company in the world. |
| 2013-04-23 | Mr. Moran received a Bachelor’s Degree from the University of Notre Dame, and holds a Master’s degree in business administration from the Harvard Business School. |
| 2014-04-23 | Mr. Moran received a Bachelor’s Degree from the University of Notre Dame, and holds a Master’s degree in business administration from the Harvard Business School. Mr. Moran’s qualifications include his prior experience in running an orthopedic division and his knowledge of the medical device industry. |
| 2015-04-23 | Mr. Moran received a B.A. in English from the University of Notre Dame, and holds a M.B.A. from Harvard University Business School. His qualifications include experience in running an orthopedic division and knowledge of the medical device industry. |
Data sourced from SEC filings. Last updated: 2025-10-12